Related Experiment Video
Updated: Jul 16, 2025
08:03
Recording EEG in Freely Moving Neonatal Rats Using a Novel Method
Published on: May 29, 2017
13.3K
[Developmental and epileptic encephalopathy. What is new?]
1Nationwide Children's Hospital, The Ohio State University, Columbus. Ohio, EE.UU.
Medicina
|September 15, 2023
Summary
Recent advancements in developmental and epileptic encephalopathies focus on updated terminology and diagnostic criteria. New gene therapies show promise for improving seizure control and cognitive outcomes, enhancing patient quality of life.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Context:
- Developmental and epileptic encephalopathies (DEE) represent a group of severe early-onset neurological disorders.
- Accurate diagnosis and classification are crucial for effective management and research.
Purpose:
- To review recent changes in DEE terminology and diagnostic criteria over the past decade.
- To analyze novel therapeutic strategies, particularly gene modulation therapies, for seizure management.
Summary:
- The article discusses evolving definitions and diagnostic standards for specific DEEs based on a 10-year review.
- It highlights new treatments demonstrating efficacy in controlling seizures in affected individuals.
Impact:
- Updated classifications enhance diagnostic precision and facilitate targeted research.
- Emerging gene modulation therapies offer potential for improved seizure control, cognitive function, and overall quality of life in DEE patients.
Related Concept Videos
01:24Arteries of the Lower Limbs
212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339
01:13Seizures: Classification
406
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
406
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
452
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
452